Suppr超能文献

中耳胆脂瘤组织提取物中的纤溶酶原激活剂

Plasminogen activators in tissue extract of aural cholesteatoma.

作者信息

Nakamura M, Yamashiro Y, Nakahodo K, Sunagawa M, Huang G W, Kosugi T, Morimitsu T

机构信息

Department of Physiology, School of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

Laryngoscope. 1995 Mar;105(3 Pt 1):305-10. doi: 10.1288/00005537-199503000-00015.

Abstract

Using a biochemical technique, the authors characterized and identified the plasminogen activator (PA) derived from tissue extracts of six aural cholesteatomas. The results of fibrin zymography indicated that the tissue extracts of two cholesteatomas demonstrated two lytic zones on fibrin-agarose plates. One of the lytic zones was at about 72 kd, while the other zone was at about 64 kd. Using various goat immunoglobulin G (IgG)-containing antibodies (anti-human uterine tissue type PA (t-PA), anti-human low-molecular-weight (LMW) urokinase, and nonspecific goat IgG) and plasminogen-free fibrin-agarose plates, we confirmed that the cholesteatoma tissue extracts contained 72 kd t-PA and 64 kd urokinase type PA (u-PA). Furthermore, we measured the t-PA and u-PA activities in the tissue extracts selectively by parabolic rate assay. In order to estimate the PA activity, we developed optimal conditions for this assay. The specific t-PA activity ranged from 0.03 to 0.43 mIU/micrograms-protein and the specific u-PA activity ranged from 0 to 0.35 mIU/microgram-protein. The highest percentage of u-PA with respect to the total PA activity was 44.9%. However, in four of the six cases, we failed to detect u-PA activity. In the present study, we thus clarified the presence of PAs in tissue extracts of aural cholesteatomas. Furthermore, we confirmed that measureable u-PA occurred in some tissue extracts. We anticipate that the u-PA in inflammatory tissues plays an important role in the degradation of the extracellular matrix via the formation of plasmin and collagenases.

摘要

作者运用生化技术对源自六个中耳胆脂瘤组织提取物中的纤溶酶原激活剂(PA)进行了表征和鉴定。纤维蛋白酶谱分析结果表明,两个胆脂瘤的组织提取物在纤维蛋白 - 琼脂糖平板上呈现出两个溶解区。其中一个溶解区位于约72kd处,另一个位于约64kd处。使用各种含山羊免疫球蛋白G(IgG)的抗体(抗人子宫组织型PA(t - PA)、抗人低分子量(LMW)尿激酶和非特异性山羊IgG)以及不含纤溶酶原的纤维蛋白 - 琼脂糖平板,我们证实胆脂瘤组织提取物中含有72kd的t - PA和64kd的尿激酶型PA(u - PA)。此外,我们通过抛物线速率测定法选择性地测量了组织提取物中的t - PA和u - PA活性。为了评估PA活性,我们为此测定法制定了最佳条件。特异性t - PA活性范围为0.03至0.43mIU/微克蛋白质,特异性u - PA活性范围为0至0.35mIU/微克蛋白质。u - PA相对于总PA活性的最高百分比为44.9%。然而,在六个病例中的四个病例中,我们未能检测到u - PA活性。在本研究中,我们因此阐明了中耳胆脂瘤组织提取物中PA的存在。此外,我们证实了在一些组织提取物中存在可测量的u - PA。我们预计炎症组织中的u - PA通过纤溶酶和胶原酶的形成在细胞外基质的降解中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验